Mirabegron For Suspension, Extended Release
Product Images NDC 67877-890

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mirabegron (NDC 67877-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirabegron Carton Label (Mirabegron Cart B)

This text provides detailed information about Mirabegron, an extended-release oral suspension medication. It includes instructions for patients and caregivers on how to prepare and administer the suspension, the recommended dosage, storage guidelines, and warnings. The text also mentions the manufacturer and distributor of the product. The medication is intended for use according to prescribed dosage and to be stored under specific temperature conditions.*

FDA Label Image

Mirabegron Pouch Label (Mirabegron Pouch A)

FDA Label Image

Mirabegron-stru (Mirabegron Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.